STAT Inhibitors in Cancer

  • Alister C. Ward

Part of the Cancer Drug Discovery and Development book series (CDD&D)

Table of contents

  1. Front Matter
    Pages i-vii
  2. Clifford Liongue, Rowena S. Lewis, Alister C. Ward
    Pages 1-32
  3. Rachel A. O’Keefe, Jennifer R. Grandis
    Pages 33-47
  4. Suhu Liu, David Frank
    Pages 49-68
  5. Chao-Lan Yu, Richard Jove, James Turkson
    Pages 69-94
  6. Uddalak Bharadwaj, Moses M. Kasembeli, David J. Tweardy
    Pages 95-161
  7. Parisa Rasighaemi, Alister C. Ward
    Pages 163-175
  8. Back Matter
    Pages 191-195

About this book


This volume, which includes contributions from leading scientists and clinicians in the field, provides definitive, state-of-the-art information on STAT inhibitors in a biological and clinical context. It gives an overview of the biology of the STAT family of transcription factors and their role in cancer etiology. Additionally, it describes the raft of therapeutic approaches being used to inhibit STATs in the context of various cancers, covering the full spectrum of therapeutic approaches to inhibiting STATs, and presenting emerging data from clinical trials.


Alternate inhibitors Cancer Etiology Inhibitors STAT Transcription factors

Editors and affiliations

  • Alister C. Ward
    • 1
  1. 1.School of MedicineDeakin UniversityWarun PondsAustralia

Bibliographic information

  • DOI
  • Copyright Information Springer International Publishing Switzerland 2016
  • Publisher Name Humana Press, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-42947-2
  • Online ISBN 978-3-319-42949-6
  • Series Print ISSN 2196-9906
  • Series Online ISSN 2196-9914
  • Buy this book on publisher's site